Cite
Lee PH, Tu CT, Hsiao CC, et al. Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury. Stem Cells Transl Med. 2016;5(11):1473-1484doi: 10.5966/sctm.2015-0343.
Lee, P. H., Tu, C. T., Hsiao, C. C., Tsai, M. S., Ho, C. M., Cheng, N. C., Hung, T. M., & Shih, D. T. (2016). Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury. Stem cells translational medicine, 5(11), 1473-1484. https://doi.org/10.5966/sctm.2015-0343
Lee, Po-Huang, et al. "Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury." Stem cells translational medicine vol. 5,11 (2016): 1473-1484. doi: https://doi.org/10.5966/sctm.2015-0343
Lee PH, Tu CT, Hsiao CC, Tsai MS, Ho CM, Cheng NC, Hung TM, Shih DT. Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury. Stem Cells Transl Med. 2016 Nov;5(11):1473-1484. doi: 10.5966/sctm.2015-0343. Epub 2016 Jul 12. PMID: 27405780; PMCID: PMC5070504.
Copy
Download .nbib